Advertisement

Topics

Latest "Astellas Pharma 4503 Pharmaceuticals Healthcare Deals Alliances Profile" News Stories

21:18 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "Astellas Pharma 4503 Pharmaceuticals Healthcare Deals Alliances Profile" found in our extensive news archives from over 250 global news sources.

More Information about Astellas Pharma 4503 Pharmaceuticals Healthcare Deals Alliances Profile on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Astellas Pharma 4503 Pharmaceuticals Healthcare Deals Alliances Profile for you to read. Along with our medical data and news we also list Astellas Pharma 4503 Pharmaceuticals Healthcare Deals Alliances Profile Clinical Trials, which are updated daily. BioPortfolio also has a large database of Astellas Pharma 4503 Pharmaceuticals Healthcare Deals Alliances Profile Companies for you to search.

Showing "Astellas Pharma 4503 Pharmaceuticals Healthcare Deals Alliances Profile" News Articles 1–25 of 30,000+

Wednesday 20th March 2019

Opinion: The time is now for insurers, #healthcare providers, patients, regulators, policymakers, professional organizations, and industry to come together and take practical steps to speed the adoption of biosimilars. https://buff.ly/2UMztaJ 

Opinion: The time is now for insurers, #healthcare providers, patients, regulators, policymakers, professional organizations, and industry to come together and take practical steps to speed the adoption of biosimilars. https://buff.ly/2UMztaJ 


Michael Jackson’s pal Macaulay Culkin jokes about sex abuse scandal at comedy gig – Mirror Online

Michael Jackson's pal Macaulay Culkin jokes about sex abuse scandal at comedy gig Mirror OnlineParis Jackson heads to Macaulay Culkin event in LA amid her reported suicide attempt she's denied Daily MailMacaulay Culkin asks comedian ‘what was Michael Jackson like with YOU?' before bursting out laughing at live g The SunParis Jackson Supports Macaulay Culkin's Live Podcast During 'Leaving Neve...

Aeroflow Healthcare to Host April Diaper Drive to Benefit Diaper Bank of North Carolina

Aeroflow Healthcare, an Inc. 5000 fastest growing company, today announced that its Urology division will host a diaper drive from April 22-26, during national Every Kid Healthy™ Week, to benefit Diaper Bank of North Carolina. ASHEVILLE, N.C. (PRWEB) March 20, 2019 Aeroflow Healthcare, an Inc. 5000 fastest growing company, today announced that its Urology division will host a diaper drive from ...


BlueCloud, the UBER-LIKE Model of HealthCare and Clinical Research, Unveils Its Global (DDIT™) Mechanisms

Globally tested and proven mechanisms provide current members with enhanced business and compliance connectivity tools. AUSTIN, Texas (PRWEB) March 20, 2019 BlueCloud by HealthCarePoint (HCP), today announced release of ground-breaking mechanisms specifically designed to help healthcare and clinical research stakeholders around the world improve patient care, stay in compliance with local and int...

CynergisTek, Inc. Sells Managed Print Services Business to Vereco, LLC for $30 Million

Deal Allows CynergisTek to Become Pure Play Cybersecurity Company CynergisTek, Inc., (NYSE AMERICAN: CTEK), a leader in healthcare cybersecurity, privacy, and compliance, today announced that it has closed a transaction to sell the assets used in its Managed Print Services (MPS) business division for $30 million to Vereco, LLC, a leading independe...

How One Startup Plans To Win Primary Care Battle In China

Millions of people lack access to quality healthcare services and products in China, but now one company has raised millions...   

Alexion Inks Collaborations Totaling $1.3B+ with Affibody, Zealand

Alexion Pharmaceuticals today announced a pair of collaborations totaling potentially more than $1.3 billion—one partnership aimed to co-developing an autoimmune disease treatment, and another aimed at expanding Alexion’s pipeline into peptide therapies. Alexion agreed to co-develop Affibody’s Phase I bivalent antibody-mimetic ABY-039 for rare Immunoglobulin G (IgG)-mediated autoimmune disea...

STAT Plus: Mystery solved: The pharma-backed group with a lot to say on #Trump’s proposal to eliminate drug rebates. https://buff.ly/2TMV06P 

STAT Plus: Mystery solved: The pharma-backed group with a lot to say on #Trump’s proposal to eliminate drug rebates. https://buff.ly/2TMV06P 

STAT Plus: Mystery solved: the pharma-backed group with a lot to say on Trump’s pitch to end drug rebates

Mystery solved: the pharma-backed group with a lot to say on Trump’s proposal to eliminate drug rebates.

Jazz Pharma's sleep disorder treatment gets FDA nod

The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc's treatment for patients with a form of sleep disorder, the company said on Wednesday.

higi adds Singer as group vice president of network alliances

CHPA conference brings new board members

The conference saw CHPA introduce new research touting the savings

FDA approves first-ever postpartum #depression therapy: Sage Therapeutics' Zulresso http://bit.ly/2TiUNmr  #postpartumdepression #pharma

FDA approves first-ever postpartum #depression therapy: Sage Therapeutics' Zulresso http://bit.ly/2TiUNmr  #postpartumdepression #pharma

Pfizer and Merck discontinue Phase 3 avelumab ovarian cancer trial http://bit.ly/2Fi8EVd  #pharma #cancer #OvarianCancer

Pfizer and Merck discontinue Phase 3 avelumab ovarian cancer trial http://bit.ly/2Fi8EVd  #pharma #cancer #OvarianCancer

Company Profile for InCrowd, Inc.

InCrowd pioneered the field of real-time, mobile, MicroSurvey solutions for agile primary market research in the life sciences. The company accesses a 1.8 million “Crowd” of healthcare professionals worldwide, reached in 20 languages, who provide insights on demand, usually from their mobile device – insights whose exceptional targeting and quality h...

FDA Reprimands Snake Venom Firm For Pain Claims Amid Opioid Crisis

Nutra Pharma’s Nyloxin claims to relieve cancer pain and potentially help treat opioid addiction, among others, mark its products as...  

Asia Deal Watch: Zogenix Partners Japanese Rights To Pediatric Epilepsy Therapy To Nippon Shinyaku

Nippon Shinyaku obtains rights to sell Dravet and Lennox-Gastaut syndrome drug Fintepla in its home market. Sun Pharma increases its...   

Poor removal of protective clothing ‘contaminates’ health staff

More than a third of healthcare staff have been found to be contaminated with multi-drug resistant organisms after caring for patients colonised or infected with the bacteria, according to a US study.

Change Healthcare Begins U.S. IPO Process

Voluntis Announces End of Roche Pharma France Collaboration for ZEMY Solution

Regulatory News: Voluntis (Euronext Paris, Ticker: VTX ISIN: FR0004183960) (Paris:VTX), a company specializing in digital therapeutics, announces Roche Pharma France's decision not to pursue ZEMY'...

STAT Plus: AbbVie is sued for using Humira patent deals to block competition in the U.S.

The lawsuit appears to be the first attempt to accuse AbbVie of anti-competitive behavior by relying on a pay-to-delay scenario.

Pharma specialist opts for BioPure products to optimise hermetic sealing

S3 Process is using BioPure BioClamp and BioPure silicone gasket technology on its new PuroVaso containers for the effective handling of powders and tablets in life science applications... The post

BONESUPPORT (BONEX) - Good start in the US, CERAMENT G/V growth

Edison Investment Research - Pharmaceuticals & healthcare - Bonesupport: With its full year 2018 results, Bonesupport reported total 2018 sales of SEK96.6m, vs SEK129.3m in 2017. US sales decreased by 56% y-o-y due to the transition to the new distribution model, whereas sales in Europe increased by 22% y-o-y. Bonesupport now has 38 distributors in the US, and achieved SEK4.2m in sales in Q418 und...

The Top 10 Highest — and Lowest — Ranked Places to Work in Pharma

How pharma companies fair on Glassdoor.

Alexion and Affibody Announce Partnership to Co-Develop Anti-FcRn Affibody Molecule

BOSTON & SOLNA, Sweden–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Affibody AB today announced a partnership to co-develop ABY-039 for rare Immunoglobulin G (IgG)-mediated autoimmune diseases. Currently in Phase 1 development, ABY-039 is a bivalent antibody-mimetic that targets the neonatal Fc receptor (FcRn). ABY-039 has been specifically designed to combine A...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks